{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:47:44Z","timestamp":1782510464145,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jval.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:02:13Z","timestamp":1769011333000},"page":"1235-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transparency, Repricing, and Price Convergence in Cancer Care"],"prefix":"10.1016","volume":"29","author":[{"given":"Forrest","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Boe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dimaano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak J.","family":"Mehrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Matros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle H.","family":"Rochlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jval.2026.01.002_bib1","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical care costs associated with cancer survivorship in the United States","volume":"29","author":"Mariotto","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jval.2026.01.002_bib2","author":"Soni"},{"issue":"12","key":"10.1016\/j.jval.2026.01.002_bib3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/jnci\/djab192","article-title":"Annual report to the nation on the status of cancer, Part 2: patient economic burden associated with cancer care","volume":"113","author":"Yabroff","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jval.2026.01.002_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/jhmhp-20-68","article-title":"Addressing financial toxicity in oncology care","volume":"5","author":"Coughlin","year":"2021","journal-title":"J Hosp Manag Health Policy"},{"issue":"30","key":"10.1016\/j.jval.2026.01.002_bib5","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2013.49.1241","article-title":"Economic burden of cancer survivorship among adults in the United States","volume":"31","author":"Guy","year":"2013","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jval.2026.01.002_bib6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1377\/hlthaff.2013.1425","article-title":"Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults","volume":"33","author":"Guy","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"6 suppl 5","key":"10.1016\/j.jval.2026.01.002_bib7","doi-asserted-by":"crossref","first-page":"S489","DOI":"10.1016\/j.amepre.2015.09.002","article-title":"Healthcare expenditure burden among non-elderly cancer survivors, 2008-2012","volume":"49","author":"Guy","year":"2015","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.jval.2026.01.002_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","article-title":"A systematic review of financial toxicity among cancer survivors: we can\u2019t pay the co-pay","volume":"10","author":"Gordon","year":"2017","journal-title":"Patient"},{"issue":"2","key":"10.1016\/j.jval.2026.01.002_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw205","article-title":"Financial hardships experienced by cancer survivors: a systematic review","volume":"109","author":"Altice","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.jval.2026.01.002_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1200\/JOP.2014.001406","article-title":"Patient-oncologist cost communication, financial distress, and medication adherence","volume":"10","author":"Bestvina","year":"2014","journal-title":"J Oncol Pract"},{"issue":"18","key":"10.1016\/j.jval.2026.01.002_bib11","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.2010.33.3179","article-title":"Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer","volume":"29","author":"Neugut","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jval.2026.01.002_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1200\/JCO.2013.52.9123","article-title":"Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia","volume":"32","author":"Dusetzina","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jval.2026.01.002_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JOP.2014.001542","article-title":"Population-based assessment of cancer survivors\u2019 financial burden and quality of life: a prospective cohort study","volume":"11","author":"Zafar","year":"2015","journal-title":"J Oncol Pract"},{"issue":"15","key":"10.1016\/j.jval.2026.01.002_bib14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.2015.63.2232","article-title":"Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer","volume":"34","author":"Lathan","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jval.2026.01.002_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/cncr.30423","article-title":"A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment","volume":"123","author":"Shih","year":"2017","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jval.2026.01.002_bib16","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial insolvency as a risk factor for early mortality among patients with cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.jval.2026.01.002_bib17","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care?","volume":"363","author":"Porter","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jval.2026.01.002_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.19.01963","article-title":"Trends in the cost of cancer care: beyond drugs","volume":"38","author":"Laviana","year":"2020","journal-title":"J Clin Oncol"},{"issue":"229","key":"10.1016\/j.jval.2026.01.002_bib21","first-page":"65524","article-title":"Medicare and Medicaid Programs: CY 2020 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates: Price Transparency Requirements for Hospitals to Make Standard Charges Public","volume":"84","year":"2019","journal-title":"Fed Regist"},{"issue":"1","key":"10.1016\/j.jval.2026.01.002_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/qje\/qjy020","article-title":"The price ain\u2019t right? Hospital prices and health spending on the privately insured","volume":"134","author":"Cooper","year":"2019","journal-title":"Q J Econ"},{"issue":"12","key":"10.1016\/j.jval.2026.01.002_bib23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jama.2024.26790","article-title":"Tracking US health care spending by health condition and county","volume":"333","author":"Dieleman","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jval.2026.01.002_bib24","doi-asserted-by":"crossref","first-page":"e245220","DOI":"10.1001\/jamahealthforum.2024.5220","article-title":"Drivers of variation in health care spending across US counties","volume":"6","author":"Dieleman","year":"2025","journal-title":"JAMA Health Forum"},{"issue":"1","key":"10.1016\/j.jval.2026.01.002_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6792","article-title":"Hospital- and county-level characteristics explain geographic variability in prices of cancer-related procedures: implications for policy and interventions","volume":"13","author":"Moss","year":"2024","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.jval.2026.01.002_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamasurg.2021.0590","article-title":"Analysis of price transparency for oncologic surgery among National Cancer Institute-designated cancer centers in 2020","volume":"156","author":"Xiao","year":"2021","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.jval.2026.01.002_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamainternmed.2022.1022","article-title":"Hospital-administered cancer therapy prices for patients with private health insurance","volume":"182","author":"Xiao","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.jval.2026.01.002_bib28","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jamaoncol.2021.4979","article-title":"Compliance with price transparency rules at US National Cancer Institute-designated cancer centers","volume":"7","author":"Chino","year":"2021","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.jval.2026.01.002_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamaoncol.2019.5690","article-title":"Analysis of price transparency via National Cancer Institute-designated cancer Centers\u2019 chargemasters for prostate cancer radiation therapy","volume":"6","author":"Agarwal","year":"2020","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.jval.2026.01.002_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jamasurg.2022.6402","article-title":"Commercial price variation for breast reconstruction in the era of price transparency","volume":"158","author":"Rochlin","year":"2023","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.jval.2026.01.002_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jama.2021.8535","article-title":"Payer-negotiated prices in the diagnosis and management of thyroid cancer in 2021","volume":"326","author":"Xiao","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jval.2026.01.002_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/SLA.0000000000006091","article-title":"Negotiated rates for surgical cancer care in the era of price transparency- prices reflect market competition","volume":"279","author":"Rochlin","year":"2024","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.jval.2026.01.002_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/PRS.0000000000011021","article-title":"Free flap reconstruction in the era of commercial price transparency: what are we paying for?","volume":"153","author":"Rochlin","year":"2024","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.jval.2026.01.002_bib34","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1245\/s10434-024-15298-6","article-title":"Oncologic surgery in the United States: do you get what you pay for?","volume":"31","author":"Marmor","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.jval.2026.01.002_bib35","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/jamaoncol.2022.1783","article-title":"Assessment of compliance with Centers for Medicare & Medicaid Services price transparency final rule","volume":"8","author":"Mathew","year":"2022","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.jval.2026.01.002_bib36","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2022.3125","article-title":"Compliance of National Cancer Institute-designated cancer centers with January 2021 price transparency requirements","volume":"157","author":"Childers","year":"2022","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.jval.2026.01.002_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1200\/OP.21.00751","article-title":"Do federal price transparency regulations neglect oncology patients?","volume":"18","author":"Prasad","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jval.2026.01.002_bib40","author":"Wang"},{"issue":"10","key":"10.1016\/j.jval.2026.01.002_bib42","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1377\/hlthaff.2016.0693","article-title":"Marketplace plans with narrow physician networks feature lower monthly premiums than plans with larger networks","volume":"35","author":"Polsky","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"10.1016\/j.jval.2026.01.002_bib43","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jval.2026.01.002_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1475-6773.12612","article-title":"Adjusting health expenditures for inflation: a review of measures for health services research in the United States","volume":"53","author":"Dunn","year":"2018","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jval.2026.01.002_bib47","series-title":"An Introduction to the Economics of Medical Care (Chap 1). Health Care Economics","first-page":"1","author":"Feldstein","year":"2012"},{"issue":"2","key":"10.1016\/j.jval.2026.01.002_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/261816","article-title":"Convergence","volume":"100","author":"Barro","year":"1992","journal-title":"J Polit Econ"},{"issue":"2","key":"10.1016\/j.jval.2026.01.002_bib49","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.econlet.2005.05.026","article-title":"\u03b2 and \u03c3-convergence: a mathematical relation of causality","volume":"89","author":"Furceri","year":"2005","journal-title":"Econ Lett"},{"key":"10.1016\/j.jval.2026.01.002_bib50","author":"Claxton"},{"key":"10.1016\/j.jval.2026.01.002_bib52","author":"Austin"},{"key":"10.1016\/j.jval.2026.01.002_bib53","series-title":"The Demand for Medical Care (Chap 6). Health Care Economics","first-page":"114","author":"Feldstein","year":"2012"},{"issue":"16","key":"10.1016\/j.jval.2026.01.002_bib54","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.13373","article-title":"Association between availability of health service prices and payments for these services","volume":"312","author":"Whaley","year":"2014","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.jval.2026.01.002_bib55","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2016.4288","article-title":"Association between availability of a price transparency tool and outpatient spending","volume":"315","author":"Desai","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jval.2026.01.002_bib56","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.21410","article-title":"Patterns of use of a price transparency tool for childbirth among pregnant individuals with commercial insurance","volume":"4","author":"Gourevitch","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jval.2026.01.002_bib57","author":"Xiao"},{"key":"10.1016\/j.jval.2026.01.002_bib58","author":"Xiao"},{"issue":"10","key":"10.1016\/j.jval.2026.01.002_bib59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jacr.2025.04.037","article-title":"Hospital price transparency in action: an analysis of radiology procedure price variation in children\u2019s hospitals between 2023 and 2024","volume":"22","author":"Krotenok","year":"2025","journal-title":"J Am Coll Radiol"},{"issue":"4","key":"10.1016\/j.jval.2026.01.002_bib60","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1377\/hlthaff.2021.01476","article-title":"Trends in hospital prices paid by private health plans varied substantially across the US","volume":"41","author":"Levinson","year":"2022","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"10.1016\/j.jval.2026.01.002_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1245\/s10434-021-10244-2","article-title":"Hospital price transparency rules are inadequate to inform patients needing major gastrointestinal cancer operations","volume":"29","author":"Herb","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"10.1016\/j.jval.2026.01.002_bib62","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jama.2019.13978","article-title":"Waste in the US health care system: estimated costs and potential for savings","volume":"322","author":"Shrank","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2026.01.002_bib63","article-title":"Estimating the impact of new health price transparency policies","volume":"60","author":"Parente","year":"2023","journal-title":"Inquiry"},{"key":"10.1016\/j.jval.2026.01.002_bib64","author":"White"},{"key":"10.1016\/j.jval.2026.01.002_bib65","author":"Kurani"},{"issue":"5","key":"10.1016\/j.jval.2026.01.002_bib66","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1245\/s10434-024-16738-z","article-title":"Lower commercial rates for breast surgical procedures are associated with socioeconomic disadvantage: a transparency in coverage analysis","volume":"35","author":"Rochlin","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jval.2026.01.002_bib67","doi-asserted-by":"crossref","DOI":"10.62186\/001c.125154","article-title":"Determining a meaningful R-squared value in clinical medicine","author":"Gupta","year":"2024","journal-title":"Acad Med Surg"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:04:13Z","timestamp":1782507853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301526000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1098301526000240"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2026.01.002","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transparency, Repricing, and Price Convergence in Cancer Care","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}